Wird geladen...
Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Canavan disease (CD) is a fatal leukodystrophy caused by mutation of the aspartoacylase (ASPA) gene, which leads to deficiency in ASPA activity, accumulation of the substrate N‐acetyl‐L‐aspartate (NAA), demyelination, and spongy degeneration of the brain. There is neither a cure nor a standard treat...
Gespeichert in:
| Veröffentlicht in: | Adv Sci (Weinh) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709977/ https://ncbi.nlm.nih.gov/pubmed/33304759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002155 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|